Filing Details
- Accession Number:
- 0000902664-22-004774
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-08 17:19:32
- Reporting Period:
- 2021-01-26
- Accepted Time:
- 2022-11-08 17:19:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1651944 | Dermtech Inc. | DMTK | () | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1493215 | Rtw Investments, Lp | 40 10Th Avenue 7Th Floor New York NY 10014 | No | No | Yes | No | |
1493280 | Roderick Wong | C/O Rtw Investments, Lp 40 10Th Avenue, 7Th Floor New York NY 10014 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-01-26 | 31,450 | $9.54 | 3,118,666 | No | 4 | X | Indirect | See footnote |
Common Stock | Disposition | 2022-11-04 | 100,000 | $1.77 | 3,018,666 | No | 4 | S | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | X | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrants to Purchase Common Stock | Disposition | 2021-01-26 | 31,450 | $9.54 | 31,450 | $9.54 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2019-08-29 | 2021-03-07 | No | 4 | X | Indirect |
Footnotes
- This Form 4 is being filed by each of (i) RTW Investments, LP (the "Adviser") with respect to the shares of common stock held by certain investment funds managed by the Adviser (the "RTW Funds") and (ii) Roderick Wong, M.D., who serves as the Managing Partner and Chief Investment Officer of the Adviser.